BSECompany Update3 Nov 2026 · 3 Nov 2026, 07:51 pm
Audio Recording of the Investor Call - Q2 & H1FY27
Camlin Fine Sciences Ltd · 532834
✦ AI SummaryResults
Camlin Fine Sciences Ltd has made available the audio recording of its conference call on Q2 and H1FY27 un-audited financial results, held on November 3, 2026, at its website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Camlin Fine Sciences Ltd - 532834 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
50206550-b4ec-4ee9-8ade-88e8057efb91.pdf
View document text
November 3, 2026
To, To,
BSE Limited, Listing Department,
25, P. J. Towers, National Stock Exchange of India Ltd.,
Dalal Street, Exchange Plaza, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (East), Mumbai- 400051
R ef: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ
Sub: Audio recording of the conference call on the Un-audited Financial Results (Consolidated
and Standalone) for the quarter ended and half year September 30, 2026.
In continuation of our disclosures dated October 29, 2026 and November 3, 2026 and pursuant to
Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”), the audio recording of the conference
call held today i.e. on Tuesday, November 3, 2026 on the Un-audited Financial Results (Consolidated
and Standalone) for the quarter and half year ended September 30, 2026 is available at the Company’s
website at https://www.camlinfs.com/investor-relations/home/investor_call_recording.
The Management was represented by Mr. Nirmal Momaya, Managing Director, Mr. Santosh Parab,
President - Strategy & Global CFO and Mr. Pankaj Pandey, Chief Financial Officer.
Discussions were based on publicly available information. No unpublished price sensitive information
(UPSI) was discussed during the interactions.
We request you to take the above on record and the same be treated as compliance under the
applicable Regulations of SEBI Listing Regulations.
Thanking You,
For Camlin Fine Sciences Limited
Rahul Sawale
Company Secretary
& VP Legal